KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 151 filers reported holding KITE PHARMA INC in Q1 2015. The put-call ratio across all filers is 1.21 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $16,549,000 | +69.4% | 159,631 | +28.3% | 0.12% | +68.1% |
| Q1 2017 | $9,767,000 | -53.3% | 124,436 | -73.3% | 0.07% | -55.3% |
| Q4 2016 | $20,918,000 | +57.5% | 466,492 | +96.2% | 0.16% | +51.9% |
| Q3 2016 | $13,279,000 | +21.5% | 237,718 | +8.7% | 0.11% | +17.8% |
| Q2 2016 | $10,930,000 | -46.9% | 218,601 | -51.2% | 0.09% | -45.1% |
| Q1 2016 | $20,565,000 | +30.0% | 447,941 | +74.5% | 0.16% | +25.2% |
| Q4 2015 | $15,822,000 | -61.5% | 256,764 | -65.2% | 0.13% | -62.1% |
| Q3 2015 | $41,096,000 | -32.3% | 738,066 | -25.9% | 0.35% | -20.6% |
| Q2 2015 | $60,702,000 | +45.6% | 995,604 | +37.7% | 0.44% | +44.9% |
| Q1 2015 | $41,690,000 | +175.7% | 722,774 | +175.6% | 0.30% | +171.2% |
| Q4 2014 | $15,124,000 | +354.4% | 262,249 | +124.6% | 0.11% | +311.1% |
| Q3 2014 | $3,328,000 | +37.1% | 116,775 | +39.1% | 0.03% | +50.0% |
| Q2 2014 | $2,428,000 | – | 83,960 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|